Results 51 to 60 of about 149 (146)
Abstract Background Dysphagia significantly impacts prognosis in individuals with multiple system atrophy (MSA). While video‐based assessments are practical, their limited availability highlights the need for a simple tool such as the Dysphagia Severity Scale (DSS) in clinical practice.
Ryunosuke Nagao+8 more
wiley +1 more source
Progranulin Mutation Manifesting as Parkinson Disease: A Case Series from the PADUA‐CESNE Cohort
Abstract Background Mutations in progranulin (GRN) are associated with frontotemporal dementia, although a Parkinson disease (PD) phenotype is uncommon, especially in young patients. Cases We report three subjects from the PADUA‐CESNE cohort, meeting diagnostic criteria for PD, with onset under age 55.
Giulia Bonato+8 more
wiley +1 more source
Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's Disease
Abstract Background Swallowing disorders are prevalent in Parkinson's disease (PD). Swallowing assessment often relies on patient‐reported outcome measures (PROMs). Although PROMs and physiologic swallowing measures correlate with disease severity, the relationship between PROMs and physiologic swallowing impairments is unclear.
Rabab Rangwala+4 more
wiley +1 more source
Abstract Background Pallidal neurostimulation is an effective treatment for severe isolated dystonia, but long‐term data from clinical trials are lacking. Objectives To evaluate long‐term efficacy and safety of pallidal neurostimulation in patients with isolated generalized or segmental dystonia.
Patricia Krause+60 more
wiley +1 more source
Abstract Background A previous case series showed that Nocebo Hypothesis Cognitive Behavioral Therapy (NH‐CBT) is a promising treatment for Functional Neurological Symptom Disorder (FNSD). Objectives To further evaluate the potential efficacy of NH‐CBT in participants with FNSD (motor type).
Matt Richardson+2 more
wiley +1 more source
Misophonia in Tic Disorders and Their Neuropsychiatric Associations
Movement Disorders Clinical Practice, EarlyView.
Arjun Balachandar+5 more
wiley +1 more source
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that has no cure, and treatments predominantly focus on improving quality of life. Patient‐centred care is central to bringing about meaningful improvements to quality of life.
A. Clift+4 more
wiley +1 more source
ABSTRACT Introduction/Aims Sevasemten (EDG‐5506) is an orally administered, investigational small molecule that selectively modulates fast muscle fiber contraction by inhibiting fast myosin ATPase. This study assessed the safety, tolerability, and pharmacokinetics (PK)/pharmacodynamics (PD) of sevasemten in healthy adult volunteers (HVs) and adults ...
Joanne Donovan+11 more
wiley +1 more source
Abstract Objective To investigate the effects of modified central‐part laryngectomy with pharyngeal space reduction (CPL‐PR) on patients with weak deglutitive pharyngeal contraction, as seen in late‐stage amyotrophic lateral sclerosis (ALS). Study Design Retrospective case series. Setting Single‐institution academic center.
Rumi Ueha+8 more
wiley +1 more source